scholarly article | Q13442814 |
P50 | author | Kevin V Hackshaw | Q90317143 |
P2093 | author name string | Lianbo Yu | |
M Mónica Giusti | |||
Gregory T Sigurdson | |||
Luis Rodriguez-Saona | |||
Francesca Madiai | |||
Marcal Plans | |||
Didem P Aykas | |||
Charles A T Buffington | |||
P2860 | cites work | An Inventory for Measuring Depression | Q26778503 |
Metabolomics analysis and modeling suggest a lysophosphocholines-PAF receptor interaction in fibromyalgia | Q27346943 | ||
The McGill Pain Questionnaire: Major properties and scoring methods | Q28205026 | ||
A review of near infrared spectroscopy and chemometrics in pharmaceutical technologies | Q28300682 | ||
The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee | Q29618782 | ||
An inventory for measuring clinical anxiety: psychometric properties | Q29619838 | ||
Overlapping Chronic Pain Conditions: Implications for Diagnosis and Classification | Q30248205 | ||
The Revised Fibromyalgia Impact Questionnaire (FIQR): validation and psychometric properties | Q30490283 | ||
A diagnostic biomarker profile for fibromyalgia syndrome based on an NMR metabolomics study of selected patients and controls | Q33660504 | ||
The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity | Q34114866 | ||
OMERACT-based fibromyalgia symptom subgroups: an exploratory cluster analysis | Q34459831 | ||
Fibromyalgia: an afferent processing disorder leading to a complex pain generalized syndrome. | Q34627659 | ||
Central sensitivity syndromes: a new paradigm and group nosology for fibromyalgia and overlapping conditions, and the related issue of disease versus illness | Q34735332 | ||
Improving the recognition and diagnosis of fibromyalgia | Q34887973 | ||
The Prevalence and Characteristics of Fibromyalgia in the 2012 National Health Interview Survey | Q35778493 | ||
A pilot study of health and wellness coaching for fibromyalgia | Q36184906 | ||
Vibrational spectroscopy for molecular characterisation and diagnosis of benign, premalignant and malignant skin tumours | Q36282661 | ||
Raman spectroscopy of synovial fluid as a tool for diagnosing osteoarthritis | Q37250703 | ||
A candidate serum biomarker for bladder pain syndrome/interstitial cystitis | Q37367661 | ||
Use of Fourier-transform infrared spectroscopy in the diagnosis of rheumatoid arthritis: a pilot study. | Q37405209 | ||
Vibrational spectroscopy: a clinical tool for cancer diagnostics | Q37498373 | ||
Applications of Infrared and Raman Spectroscopies to Probiotic Investigation | Q37577481 | ||
Diagnostic criteria for systemic lupus erythematosus: a critical review | Q38181673 | ||
Editorial review: an update on central sensitivity syndromes and the issues of nosology and psychobiology | Q38542259 | ||
Clinical and investigative applications of Raman spectroscopy in Urology and Andrology | Q38713747 | ||
A Comparative Evaluation of the 2011 and 2016 Criteria for Fibromyalgia | Q38749976 | ||
The pathogenesis of chronic pain and fatigue syndromes, with special reference to fibromyalgia | Q40959949 | ||
Combining Raman and FT-IR spectroscopy with quantitative isotopic labeling for differentiation of E. coli cells at community and single cell levels | Q41128709 | ||
HMDB 4.0: the human metabolome database for 2018. | Q43212324 | ||
Evidence for an altered tryptophan metabolism in fibromyalgia | Q44315184 | ||
HU protein employs similar mechanisms of minor-groove recognition in binding to different B-DNA sites: demonstration by Raman spectroscopy | Q44479670 | ||
Employees with fibromyalgia: medical comorbidity, healthcare costs, and work loss | Q45288463 | ||
The MOS short-form general health survey. Reliability and validity in a patient population | Q46080503 | ||
Subgroups of fibromyalgia patients using the 1990 American College of Rheumatology criteria and the modified 2010 preliminary diagnostic criteria: the al-Ándalus project. | Q47995746 | ||
Detection of glycosylation and iron-binding protein modifications using Raman spectroscopy | Q48264659 | ||
The impact of a diagnosis of fibromyalgia on health care resource use by primary care patients in the UK: an observational study based on clinical practice | Q48519165 | ||
Health economic consequences related to the diagnosis of fibromyalgia syndrome | Q49030047 | ||
2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative | Q56506042 | ||
Systemic lupus erythematosus disease activity index 2000 | Q77624632 | ||
The economic burden of fibromyalgia: comparative analysis with rheumatoid arthritis | Q83359788 | ||
A bloodspot-based diagnostic test for fibromyalgia syndrome and related disorders | Q86612466 | ||
P433 | issue | 7 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | fibromyalgia | Q540571 |
P304 | page(s) | 2555-2568 | |
P577 | publication date | 2018-12-06 | |
P1433 | published in | Journal of Biological Chemistry | Q867727 |
P1476 | title | Metabolic fingerprinting for diagnosis of fibromyalgia and other rheumatologic disorders | |
P478 | volume | 294 |
Q89879650 | Identification of MOR-Positive B Cell as Possible Innovative Biomarker (Mu Lympho-Marker) for Chronic Pain Diagnosis in Patients with Fibromyalgia and Osteoarthritis Diseases |
Q100684192 | Metabolomics in Chronic Pain Research |
Q97549268 | Spectrochemical analysis in blood plasma combined with subsequent chemometrics for fibromyalgia detection |
Search more.